Exogenous Cushing Syndrome pada Kasus Systemic Lupus Erythematosus
DOI:
https://doi.org/10.31004/koloni.v5i2.895Keywords:
Exogenous Cushing Syndrome, cortisol, glucocorticoidAbstract
Cushing's syndrome (CS) is a group of signs and symptoms caused by chronic exposure to excess glucocorticoids. There are two types of Cushing's syndrome, endogenous and exogenous. Exogenous Cushing's syndrome, is a consequence of prolonged exposure to glucocorticoid drugs. Hypercortisolism is characterized by specific clinical features (moon face, facial plethora, striae rubrae, and supraclavicular and dorsal fat pads), as well as metabolic complications such as visceral obesity, hypertension, diabetes, dyslipidemia, osteoporosis, and detrimental effects on the brain, including hippocampal damage and memory impairment. Exogenous Cushing's syndrome is characterized by low serum cortisol levels in the morning. Discontinuation of exogenous glucocorticoids is the main pillar that must be carried out in exogenous Cushing's syndromeReferences
Cai, Y., Ren, L., Tan, S., Liu, X., Li, C., Gang, X., & Wang, G. (2022). Mechanism, diagnosis, and treatment of cyclic Cushing’s syndrome: A review. In Biomedicine and Pharmacotherapy (Vol. 153). Elsevier Masson s.r.l.
Contento, M. N., Rana, S., & Brutsaert, E. (2022). Multiple Deep Vein Thromboses After Curative Surgery for Cushing Disease: A Case Presentation and Review. AACE Clinical Case Reports, 8(6), 247–250.
Ferriere, A., & Tabarin, A. (2020). Cushing’s syndrome: treatment and new therapeutic approaches.
González Clavijo, A. M., Fierro Maya, L. F., Alvarez-Lozano, M. A., Moreno-Soler, G. A., Rodríguez-Paz, S., & Tarquino-Rincón, D. (2020). Síndrome de Cushing exógeno de difícil diagnóstico. Acta Medica Colombiana, 45(3).
Nieman, L. K. (2018). Recent updates on the diagnosis and management of Cushing’s syndrome. In Endocrinology and Metabolism (Vol. 33, Number 2, pp. 139–146). Korean Endocrine Society.
Paragliola, R. M., Corsello, A., Papi, G., Pontecorvi, A., & Corsello, S. M. (2021). Cushing’s syndrome effects on the thyroid. In International Journal of Molecular Sciences (Vol. 22, Number 6, pp. 1–12). MDPI AG.
Patel, R., Sherf, S., Lai, N. B., & Yu, R. (2022). Exogenous Cushing Syndrome Caused by a “Herbal” Supplement. AACE Clinical Case Reports, 8(6), 239–242.
Pelewicz, K., & Miśkiewicz, P. (2021). Glucocorticoid withdrawal—an overview on when and how to diagnose adrenal insufficiency in clinical practice. In Diagnostics (Vol. 11, Number 4). MDPI.
Permatasari, C. A., & Marpaung, F. R. (n.d.). 738 Medico-legal Update (Vol. 21, Number 1).
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022). Approach to the Patient: Diagnosis of Cushing Syndrome. The Journal of Clinical Endocrinology and Metabolism, 107(11), 3162–3174.
Sherlock, M., & Stewart, P. M. (2019). Recovery of adrenal function in patients with central adrenal insufficiency. In Journal of Clinical Endocrinology and Metabolism (Vol. 104, Number 1, pp. 17–20). Oxford University Press.
Soelistijo, S. A., Gunawan, H., Primasatya, C. A. I., Ariana, A. M., Mudjanarko, S. W., & Pranoto, A. (2020). Sindroma Cushing Eksogen: Kapan Penggunaan Dosis Stres Glukokortikoid Bermanfaat? Jurnal Penyakit Dalam Indonesia, 7(3), 181.
Tong, C. V., & Rajoo, S. (2019). Co-Occurrence of Exogenous and Endogenous Cushing’s Syndromes-Dilemma in Diagnosis. Case Reports in Endocrinology, 2019.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 I Gusti Agung Ayu Indrayuni, Wira Gotera, Ida Bagus Aditya Nugraha3
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
